This article is substantially duplicated by a piece in an external publication. Please do not flag this article as a copyright violation of the following source:
Surhone, L. M., Tennoe, M. T., & Henssonow, S. F. (2010), Progeria: Senescence, dyskeratosis congenita, Jonathan Hutchinson, scleroderma, Betascript Publishing{{citation}}: CS1 maint: multiple names: authors list (link)
The Wikimedia Foundation's Terms of Use require that editors disclose their "employer, client, and affiliation" with respect to any paid contribution; see WP:PAID. For advice about reviewing paid contributions, see WP:COIRESPONSE.
PLEASE FOR THE LOVE OF GOD CLEAN UP THIS PAGE!! This looks like a really interesting syndrome/condition. However, I have to use the dictionary a lot to understand it. Readability is important! Too much technical jargon-- please clean up. MiniOreo (talk) 14:00, 12 May 2008 (UTC)[reply]
Not premature aging
"premature aging effect" is scientifically incorrect terminology, giving the mistaken impression that this condition is accelerated aging. I reverted to language used in my edit: "rare progressive congenital disorder which results in what in some ways resembles premature aging (similar to progeria)" --Xris0 (talk) 20:42, 30 January 2010 (UTC)[reply]
The CHARACTERISTICS section offers a lot of specific information on the symptoms of the disease, however none of it is cited.
Cheesefromwater (talk) 14:34, 6 January 2015 (UTC)[reply]
Proposed updates to existing section ‘4. Diagnosis’
This edit request by an editor with a conflict of interest has now been answered.
Please update content to: Since the disease has a wide variety of symptoms, due to the involvement of multiple body systems, diagnostic testing depends on the clinical findings in each individual patient. Commonly used tests include: complete blood count (CBC), bone marrow examination, leukocyte telomere length test (e.g. Flow FISH [1]), pulmonary function test, genetic testing and checking for von Willebrand factor (VMF [2]) level in the blood.
Explanation of issue: Bad grammar; formatting issues; two clinically utilized methods of Dyskeratosis Congenita diagnosis currently not mentioned
References supporting change:
Alter BP, Baerlocher GM, Savage SA, et al. Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. Blood. 2007;110(5):1439-1447. doi:10.1182/blood-2007-02-075598. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1975834/
Hi @JLRD309:, I do not have medical expertise nor experience editing medical articles, so I decided to post a notice to WP:WikiProject Medicine. Hopefully someone there will respond soon. I have also moved your connected contributor banner to the top of the page. Z1720 (talk) 16:35, 27 November 2020 (UTC)[reply]
Also, I haven't found any other sources that mention VMF, and I wonder whether that is still done or perhaps not a key step in the diagnosis. WhatamIdoing (talk) 20:53, 27 November 2020 (UTC)[reply]
Hi @JLRD309:, I want to make sure you got the note from WhatamIdoing. If you wish to respond please post it below. If there's no response for a couple days I will close the ticket. Thanks. Z1720 (talk) 03:12, 4 December 2020 (UTC)[reply]
Since there has not been a response to WhatamIdoing by the original requester, I am going to close this ticket. If you would like to request these changes again please follow the instructions at Template:Request edit/Instructions. Happy editing! Z1720 (talk) 18:06, 6 December 2020 (UTC)[reply]
Changes to section 4. Diagnosis
The Wikimedia Foundation's Terms of Use require that editors disclose their "employer, client, and affiliation" with respect to any paid contribution; see WP:PAID. For advice about reviewing paid contributions, see WP:COIRESPONSE.
This edit request by an editor with a conflict of interest has now been answered.
Content to be updated to: Since the disease has a wide variety of symptoms, due to the involvement of multiple body systems, diagnostic testing depends on the clinical findings in each individual patient. Commonly used tests include: complete blood count (CBC), bone marrow examination, leukocyte telomere length test (e.g. Flow FISH [3]), pulmonary function test and genetic testing.
Explanation of issue: Bad grammar; formatting issues; two clinically utilized methods of Dyskeratosis Congenita diagnosis currently not mentioned; no references to support link between von Willibrand factor and diagnosis of dyskeratosis congenita
References supporting change:
Savage SA. Dyskeratosis Congenita. 2009 Nov 12 [Updated 2019 Nov 21]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2020. https://www.ncbi.nlm.nih.gov/books/NBK22301/#dkc.Diagnosis
@WhatamIdoing: Thanks for your guidance on referencing and for flagging lack of reference for von Willibrand factor, I have no knowledge of a link between this and dyskeratosis congenita diagnosis, I have therefore suggested it is removed.
Thank you for this, JLRD309. I apologize for taking so long to get back to you. By the way, some of us who are interested in medical content hang out at Wikipedia talk:WikiProject Medicine. You are welcome to put the page on your watchlist and join the discussions. We always need people who know things. ;-DWhatamIdoing (talk) 22:07, 27 December 2020 (UTC)[reply]